Efficacy and Safety of Nirmatrelvir/Ritonavir, Molnupiravir, and Remdesivir in a Real-World Cohort of Outpatients with COVID-19 at High Risk of Progression: the PISA Outpatient Clinic ExperienceGiusy Tiseo,Chiara Barbieri,Valentina Galfo,Sara Occhineri,Tommaso Matucci, Francesco Almerigogna, Jona Kalo,Pietro Sponga,Mario Cesaretti,Gabriele Marchetti,Arianna Forniti,Claudio Caroselli,Simone Ferranti,Manuela Pogliaghi,Marina Polidori,Silvia Fabiani,Stefano Verdenelli,Enrico Tagliaferri,Niccolò Riccardi,Lorenzo Roberto Suardi,Claudia Carmignani, Serena Batini, Luca Puccetti,Riccardo Iapoce,Francesco Menichetti,Marco FalconeInfectious Diseases and Therapy（2022）引用 18|浏览30暂无评分关键词COVID-19,SARS-CoV-2,Molnupiravir,Nirmatrelvir/ritonavir,Remdesivir,ProgressionAI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
